PASD1 is a potential multiple myeloma–associated antigen
Open Access
- 1 December 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (12) , 3953-3955
- https://doi.org/10.1182/blood-2006-04-014621
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Protein Expression Profiles Confirm PASD1 as a Cancer Testis Antigen and a Potential Candidate for Lymphoma Immunotherapy.Blood, 2005
- The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferationBlood, 2005
- A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain proteinBritish Journal of Cancer, 2004
- Donor Lymphocyte Infusions for Relapsed Multiple Myeloma After Allogeneic Stem-Cell Transplantation: Predictive Factors for Response and Long-Term OutcomeJournal of Clinical Oncology, 2000
- Localization of the MAGE1 gene encoding a human melanoma antigen to chromosome Xq28Cytogenetic and Genome Research, 1994